BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

212 related articles for article (PubMed ID: 11052327)

  • 1. Optimization of technetium-99m-HMPAO leukocyte scintigraphy in evaluation of active inflammatory bowel disease.
    Sans M; Fuster D; Llach J; Lomeña F; Bordas JM; Herranz R; Piqué JM; Panés J
    Dig Dis Sci; 2000 Sep; 45(9):1828-35. PubMed ID: 11052327
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Comparison of endoscopy, radiology and scintigraphy with Tc-99m-exametazine labeled leukocytes and In-111 labeled human polyclonal immunoglobulin G in the diagnosis of inflammatory bowel disease].
    de Lima Ramos PA; Martín-Comin J; Muñoz A; Baliellas C; Vilar L; Roca M; Ramos M
    Med Clin (Barc); 1998 Sep; 111(7):241-6. PubMed ID: 9789237
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Technetium-99m HMPAO-labeled leukocyte imaging compared with endoscopy, ultrasonography, and contrast radiology in children with inflammatory bowel disease.
    Alberini JL; Badran A; Freneaux E; Hadji S; Kalifa G; Devaux JY; Dupont T
    J Pediatr Gastroenterol Nutr; 2001 Mar; 32(3):278-86. PubMed ID: 11345176
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Evaluation of 99mTc-HMPAO leukocyte scintigraphy in the investigation of pediatric inflammatory bowel disease.
    Grahnquist L; Chapman SC; Hvidsten S; Murphy MS
    J Pediatr; 2003 Jul; 143(1):48-53. PubMed ID: 12915823
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The diagnostic value of Tc-99m human polyclonal immunoglobulin imaging compared to Tc-99m HMPAO labeled leukocytes in inflammatory bowel disease.
    Delgado Castro M; Lancha C; Prats E; Mitjavilla M; Abós D; Martín-Curto LM; Crespo A; Banzo J
    Clin Nucl Med; 1997 Jan; 22(1):17-20. PubMed ID: 8993867
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Scintigraphic assessment of the severity of inflammatory bowel disease using Tc 99m exametazime-labeled leukocytes].
    de Lima Ramos PA; Martín-Comín J; Prats E; da Costa M; Guerrero L; Roca M; Muñoz A; García F; Abós M; Banzo J
    Rev Esp Med Nucl; 1998; 17(5):351-7. PubMed ID: 9812009
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Value of technetium-99m HMPAO-labelled leucocyte scintigraphy as an initial screening test in patients suspected of having inflammatory bowel disease.
    Giaffer MH; Tindale WB; Holdsworth D
    Eur J Gastroenterol Hepatol; 1996 Dec; 8(12):1195-200. PubMed ID: 8980940
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Hydrocolonic sonography for evaluating inflammatory bowel disease.
    Bru C; Sans M; Defelitto MM; Gilabert R; Fuster D; Llach J; Lomeña F; Bordas JM; Piqué JM; Panés J
    AJR Am J Roentgenol; 2001 Jul; 177(1):99-105. PubMed ID: 11418406
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Inflammatory bowel disease activity assessment using technetium-99m-HMPAO leukocytes.
    Arndt JW; Grootscholten MI; van Hogezand RA; Griffioen G; Lamers CB; Pauwels EK
    Dig Dis Sci; 1997 Feb; 42(2):387-93. PubMed ID: 9052524
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Technetium-99m hexamethyl propylene amine oxime-labeled leukocyte scintigraphy at three different times in active ulcerative colitis: comparison with colonoscopy and clinico-biochemical parameters in the assessment of disease extension and severity.
    Aydin F; Dinçer D; Güngör F; Boz A; Akça S; Yildiz A; Tosun O; Karayalçin B
    Ann Nucl Med; 2008 Jun; 22(5):371-7. PubMed ID: 18600414
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Clinical applications of technetium Tc 99m hexamethyl propylene amine oxime leukocyte scan in children with inflammatory bowel disease.
    Del Rosario MA; Fitzgerald JF; Siddiqui AR; Chong SK; Croffie JM; Gupta SK
    J Pediatr Gastroenterol Nutr; 1999 Jan; 28(1):63-70. PubMed ID: 9890471
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Active inflammatory bowel disease: evaluation with 99mTc (V) DMSA scintigraphy.
    Koutroubakis IE; Koukouraki SI; Dimoulios PD; Velidaki AA; Karkavitsas NS; Kouroumalis EA
    Radiology; 2003 Oct; 229(1):70-4. PubMed ID: 12925713
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Detection of inflammatory bowel disease in pediatric patients with technetium-99m-HMPAO-labeled leukocytes.
    Charron M; Orenstein SR; Bhargava S
    J Nucl Med; 1994 Mar; 35(3):451-5. PubMed ID: 8113895
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Leukocyte scintigraphy compared to intraoperative small bowel enteroscopy and laparotomy findings in Crohn's disease.
    Almer S; Granerus G; Ström M; Olaison G; Bonnet J; Lémann M; Smedh K; Franzén L; Bertheau P; Cattan P; Rain JD; Modigliani R
    Inflamm Bowel Dis; 2007 Feb; 13(2):164-74. PubMed ID: 17206712
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Technetium Tc 99m hexamethyl propylene amine oxine leukocyte scintigraphy in patients with ulcerative colitis: correlation with clinical, biologic, endoscopic, and pathologic intensity, and local release of interleukin 8.
    Guimbaud R; Beades E; Chauvelot-Moachon L; Quartier G; Gaudric M; Bertrand V; Cellier C; Vidon N; Devaux JY; Richard B; Couturier D; Chaussade S
    Gastrointest Endosc; 1998 Nov; 48(5):491-6. PubMed ID: 9831837
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Inflammatory bowel disease in pediatric patients.
    Charron M
    Q J Nucl Med; 1997 Dec; 41(4):309-20. PubMed ID: 9542422
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Technetium-99m hexamethylpropyleneamine-oxime-labeled leukocyte scintigraphy in inflammatory bowel disease in children.
    Bhargava SA; Orenstein SR; Charron M
    J Pediatr; 1994 Aug; 125(2):213-7. PubMed ID: 8040764
    [TBL] [Abstract][Full Text] [Related]  

  • 18. 99mTc-interleukin-2 and (99m)Tc-HMPAO granulocyte scintigraphy in patients with inactive Crohn's disease.
    Annovazzi A; Biancone L; Caviglia R; Chianelli M; Capriotti G; Mather SJ; Caprilli R; Pallone F; Scopinaro F; Signore A
    Eur J Nucl Med Mol Imaging; 2003 Mar; 30(3):374-82. PubMed ID: 12634965
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [99mTc-HMPAO-leukocyte-labeled scintigraphy in the detection and follow-up of inflammatory bowel disease].
    Verdú Rico J; Juste Ruiz M; Jover R; Muñoz Acosta J; Muñoz J; Martínez Caballero A; Antón Leal A; Caballero Carpena O
    An Pediatr (Barc); 2006 May; 64(5):457-63. PubMed ID: 16756887
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Technetium-99m hexamethyl propylene amine oxine leucocytes in the assessment of disease activity in inflammatory bowel disease.
    Lantto E; Järvi K; Krekelä I; Lantto T; Taavitsainen M; Vedenkangas H; Vorne M
    Eur J Nucl Med; 1992; 19(1):14-8. PubMed ID: 1547802
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.